Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • OTC Markets Disclosure
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

SEC Form 10-K for Period Ended December 31, 2018

Download

Interactive Data Files (XBRL)

Download

SEC Form S-1/A

Download

SEC Form D: Notice of Exempt Offering of Securities

Download

SEC Form 8-K: Entry Into a Material Agreement

Download

SEC 424B5 Prospectus Supplement (To Prospectus Dated January 9, 2017)

Download

SEC Form 8-K: Press Release Dated March 6, 2019

Download

SEC Form 8-K: Press Release Dated February 28, 2019

Download

Nasdaq notifying Bio-Path that it has regained compliance for continued listing on The Nasdaq Capital Market

Download

SEC Form D

Download

Bio-Path Holdings

All Rights Reserved

Office:

625 Stanwix Street
Pittsburgh, PA, 15222

T: (630) 708-0750

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • OTC Markets Disclosure
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us